Literature DB >> 28449805

Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome.

Annette Y Sunga1, Charité Ricker2, Carin R Espenschied1, Danielle Castillo1, Marilena Melas2, Josef Herzog1, Sarah Bannon3, Marcia Cruz-Correa4, Patrick Lynch3, Ilana Solomon1, Stephen B Gruber2, Jeffrey N Weitzel5.   

Abstract

Lynch syndrome (LS), the most common hereditary colorectal cancer syndrome, is caused by mismatch repair (MMR) gene mutations. However, data about MMR mutations in Hispanics are limited. This study aims to describe the spectrum of MMR mutations in Hispanics with LS and explore ancestral origins. This case series involved an IRB-approved retrospective chart review of self-identified Hispanic patients (n = 397) seen for genetic cancer risk assessment at four collaborating academic institutions in California, Texas, and Puerto Rico who were evaluated by MMR genotyping and/or tumor analysis. A literature review was conducted for all mutations identified. Of those who underwent clinical genetic testing (n = 176), 71 had MMR gene mutations. Nine mutations were observed more than once. One third (3/9) of recurrent mutations and two additional mutations (seen only once) were previously reported in Spain, confirming the influence of Spanish ancestry on MMR mutations in Hispanic populations. The recurrent mutations identified (n = 9) included both previously reported mutations as well as unique mutations not in the literature. This is the largest report of Hispanic MMR mutations in North America; however, a larger sample and haplotype analyses are needed to better understand recurrent MMR mutations in Hispanic populations.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Hispanics; Lynch syndrome; MLH1; MMR mutations; MSH2; MSH6; PMS2; colon cancer

Mesh:

Substances:

Year:  2017        PMID: 28449805      PMCID: PMC8800930          DOI: 10.1016/j.cancergen.2017.01.003

Source DB:  PubMed          Journal:  Cancer Genet


  46 in total

1.  Eight novel germline MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer families from Spain.

Authors:  J Godino; M de La Hoya; E Diaz-Rubio; M Benito; T Caldés
Journal:  Hum Mutat       Date:  2001-12       Impact factor: 4.878

2.  Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation.

Authors:  A Wagner; C Tops; J T Wijnen; K Zwinderman; C van der Meer; M Kets; M F Niermeijer; J G M Klijn; A Tibben; H F A Vasen; H Meijers-Heijboer
Journal:  J Med Genet       Date:  2002-11       Impact factor: 6.318

3.  Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.

Authors:  Mev Dominguez Valentin; Felipe Carneiro da Silva; Erika Maria Monteiro dos Santos; Bianca Garcia Lisboa; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Israel Gomy; Wilson Toshihiko Nakagawa; Samuel Aguiar Junior; Mariana Redal; Carlos Vaccaro; Adriana Della Valle; Carlos Sarroca; Dirce Maria Carraro; Benedito Mauro Rossi
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

4.  Cancer risk in mutation carriers of DNA-mismatch-repair genes.

Authors:  M Aarnio; R Sankila; E Pukkala; R Salovaara; L A Aaltonen; A de la Chapelle; P Peltomäki; J P Mecklin; H J Järvinen
Journal:  Int J Cancer       Date:  1999-04-12       Impact factor: 7.396

5.  Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.

Authors:  Lucia Pérez-Cabornero; Mar Infante Sanz; Eladio Velasco Sampedro; Enrique Lastra Aras; Alberto Acedo Becares; Cristina Miner Pino; Mercedes Durán Domínguez
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-26

6.  Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.

Authors:  Trinidad Caldes; Javier Godino; Miguel de la Hoya; Iciar Garcia Carbonero; Pedro Perez Segura; Charis Eng; Manuel Benito; Eduardo Diaz-Rubio
Journal:  Int J Cancer       Date:  2002-04-10       Impact factor: 7.396

7.  Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.

Authors:  Lucia Pérez-Cabornero; Ester Borrás Flores; Mar Infante Sanz; Eladio Velasco Sampedro; Alberto Acedo Becares; Enrique Lastra Aras; Jorge Cuevas González; Marta Pineda Riu; Teresa Ramón y Cajal Asensio; Gabriel Capellá Munar; Cristina Miner Pino; Mercedes Durán Domínguez
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-21

8.  Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying.

Authors:  Elena M Stoffel; D Kim Turgeon; David H Stockwell; Daniel P Normolle; Missy K Tuck; Norman E Marcon; John A Baron; Robert S Bresalier; Nadir Arber; Mack T Ruffin; Sapna Syngal; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

9.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Francis M Giardiello; John I Allen; Jennifer E Axilbund; C Richard Boland; Carol A Burke; Randall W Burt; James M Church; Jason A Dominitz; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David A Lieberman; Douglas J Robertson; Sapna Syngal; Douglas K Rex
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

10.  Mutation spectrum in South American Lynch syndrome families.

Authors:  Mev Dominguez-Valentin; Mef Nilbert; Patrik Wernhoff; Francisco López-Köstner; Carlos Vaccaro; Carlos Sarroca; Edenir Ines Palmero; Alejandro Giraldo; Patricia Ashton-Prolla; Karin Alvarez; Alejandra Ferro; Florencia Neffa; Junea Caris; Dirce M Carraro; Benedito M Rossi
Journal:  Hered Cancer Clin Pract       Date:  2013-12-18       Impact factor: 2.857

View more
  4 in total

1.  Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.

Authors:  Charles Muller; Sang Mee Lee; William Barge; Shazia M Siddique; Shivali Berera; Gina Wideroff; Rashmi Tondon; Jeremy Chang; Meaghan Peterson; Jessica Stoll; Bryson W Katona; Daniel A Sussman; Joshua Melson; Sonia S Kupfer
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-18       Impact factor: 11.382

2.  Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.

Authors:  Pooja Dharwadkar; Garrett Greenan; Elena M Stoffel; Ezra Burstein; Sara Pirzadeh-Miller; Sayoni Lahiri; Caitlin Mauer; Amit G Singal; Caitlin C Murphy
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-24       Impact factor: 11.382

3.  Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences.

Authors:  Shih-Ching Chang; Yuan-Tzu Lan; Pei-Ching Lin; Shung-Haur Yang; Chien-Hsing Lin; Wen-Yi Liang; Wei-Shone Chen; Jeng-Kai Jiang; Jen-Kou Lin
Journal:  Cancer Med       Date:  2019-11-25       Impact factor: 4.452

4.  A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population.

Authors:  Alejandra Padua-Bracho; José A Velázquez-Aragón; Verónica Fragoso-Ontiveros; Paulina María Nuñez-Martínez; María de la Luz Mejía Aguayo; Yuliana Sánchez-Contreras; Miguel Angel Ramirez-Otero; Marcela Angélica De la Fuente-Hernández; Silvia Vidal-Millán; Talia Wegman-Ostrosky; Abraham Pedroza-Torres; Cristian Arriaga-Canon; Luis A Herrera-Montalvo; Rosa Maria Alvarez-Gómez
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.